Homozygous familial hypercholesterolemia: the impact of novel treatments
- PMID: 38436458
- DOI: 10.1093/eurjpc/zwae094
Homozygous familial hypercholesterolemia: the impact of novel treatments
Conflict of interest statement
Conflict of interest: none declared.
Comment on
-
Contemporary lipid-lowering management and risk of cardiovascular events in homozygous familial hypercholesterolaemia: insights from the Italian LIPIGEN Registry.Eur J Prev Cardiol. 2024 Jun 3;31(8):1038-1047. doi: 10.1093/eurjpc/zwae036. Eur J Prev Cardiol. 2024. PMID: 38374534
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
